A comparative study of the osteogenic potentials of rhBMP-2 in collagen sponge or mixed with porcine collagen gel in a rat spinal fusion model

Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 4-11, 2009, Pages 653-658

  Moon, Kyoung Ho ^a   Park, In Suh ^b   Lee, Mi Ok ^a,b   Park, Hyung Chun ^b   Park, Chong Oon ^b   Hyun, Dong Keun ^b   Park, Hyeonseon ^a,b   Kim, Eun Young ^b   Kim, Kil Whan ^a   Choi, Byung Hyune ^a   Park, So Ra ^a,b   Rim, Dae Cheol ^c   Yoon, Seung Hwan ^a,b  

^a Inha University   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Hallym University   (South Korea)

Author keywords

Bone fusion; Collagen sponge; RhBMP 2; Spinal fusion

Indexed keywords

COLLAGEN SPONGE; COMPARATIVE STUDIES; INTERTRANSVERSE PROCESS; OSTEOGENIC POTENTIAL; RADIOGRAPHIC ASSESSMENT; RHBMP-2; SPINAL FUSION; TOMOGRAPHIC SCANNING;

BONE; COMPUTERIZED TOMOGRAPHY; IMPLANTS (SURGICAL); RATS; TOMOGRAPHY;

COLLAGEN;

EID: 84884565371     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. A Horowitch, RD Peek, JC Thomas, et al., The wiltse pedicle screw fixation system, early clinical results, Spine, 14, 461 (1989).
2. SD Boden, Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation, Tissue Eng, 6, 383 (2000).
3. SD Boden, J Kang, H Sandhu, et al., Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial, 2002 Volvo Award in clinical studies, Spine, 27, 2662 (2002).
4. K Tsuchiya, KH Bridwell, TR Kuklo, et al., Minimum 5-year analysis of L5-S1 fusion using sacropelvic fixation(bilateral S1 and iliac screws) for spinal deformity, Spine, 31, 303 (2006).
5. JR Dimar, SD Glassman, KJ Burkus, et al., Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft, Spine, 31, 2534 (2006).
6. C Papakostidis, G Kontakis, M Bhandari, et al., Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results, Spine, 33, E680 (2008).
7. D Benglis, MY Wang, AD Levi, A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery, Neurosurgery, 62, 423 (2008).
8. TP Lovell, EG Dawson, OS Nilsson, et al., Augmentation of spinal fusion with bone morphogenetic protein in dogs, Clin Orthop Relat Res, 266 (1989).
9. A Minamide, T Tamaki, M Kawakami, et al., Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein- 2, Spine, 24, 1863, discussion 1871-1862 (1999)
10. Y Okubo, K Bessho, K Fujimura, et al., Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites, Int J Oral Maxillo fac Surg 29, 62 (2000).
11. K Uludagx, D D'Augusta, J Golden, et al., Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model, J Biomed Mater Res, 50, 227 (2000).
12. JK Burkus, JD Dorchak, DL Sanders, Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2, Spine, 28, 372 (2003).
13. K Fujimura, K Bessho, K Kusumoto, et al., Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2, Biochem Biophys Res Commun, 208, 316 (1995).
14. K Kusumoto, K Bessho, K Fujimura, et al., Osteoinduction by recombinant human bone morphogenetic protein-2 in muscles of non-human primates, J Int Med Res, 30, 251 (2002).
15. N Kakudo, K Kusumoto, A Kuro, et al., Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats, Wound Repair Regen, 14, 336 (2006).
16. M Yamamoto, Y Takahashi, Y Tabata, Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel, Tissue Eng, 12, 1305 (2006).
17. DS Keskin, A Tezcaner, P Korkusuz, et al., Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair, Biomaterials, 26, 4023 (2005).
18. VV Patel, L Zhao, P Wong, et al., An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth, Spine J, 6, 397 (2006).
19. M Kato, H Toyoda, T Namikawa, et al., Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein- 2(rhBMP-2), Biomaterials, 27, 2035 (2006).
20. M Miyazaki, Y Morishita, W He, et al., A porcine collagenderived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats, Spine J, 9, 22 (2009).
21. DP Magit, T Maak, N Trioano, et al., Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model, Spine, 31, 2180 (2006).
22. HW Liu, CH Chen, CL Tsai, et al., Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation, Bone, 39, 825 (2006).
23. JP Issa, C do Nascimento, MM Iyomasa, et al., Bone healing process in critical-sized defects by rhBMP-2 using poloxamer gel and collagen sponge as carriers, Micron, 39, 17 (2008).
24. YK Ko, SH Kim, HJ Ha, et al., Tissue engineered biodisc using human intervertebral disc cells and PLGA/DBP scaffold, Tissue Eng Regen Med, 4(1), 67 (2007).
25. G Khang, SH Kim, MS Kim, et al., Recent and future directions of stem cells for the application of regenerative medicine, Tissue Eng Regen Med, 4(4), 441 (2007).
26. IY Kim, JH Chung, YJ Choi, et al., Protein and gene delivery in tissue engineering, Tissue Eng Regen Med, 5(4∼6), 671 (2008).